32 research outputs found

    Distinct Kinetics of Memory B-Cell and Plasma-Cell Responses in Peripheral Blood Following a Blood-Stage Plasmodium chabaudi Infection in Mice

    Get PDF
    B cell and plasma cell responses take place in lymphoid organs, but because of the inaccessibility of these organs, analyses of human responses are largely performed using peripheral blood mononuclear cells (PBMC). To determine whether PBMC are a useful source of memory B cells and plasma cells in malaria, and whether they reflect Plasmodium-specific B cell responses in spleen or bone marrow, we have investigated these components of the humoral response in PBMC using a model of Plasmodium chabaudi blood-stage infections in C57BL/6 mice. We detected memory B cells, defined as isotype-switched IgD− IgM− CD19+ B cells, and low numbers of Plasmodium chabaudi Merozoite Surface Protein-1 (MSP1)-specific memory B cells, in PBMC at all time points sampled for up to 90 days following primary or secondary infection. By contrast, we only detected CD138+ plasma cells and MSP1-specific antibody-secreting cells within a narrow time frame following primary (days 10 to 25) or secondary (day 10) infection. CD138+ plasma cells in PBMC at these times expressed CD19, B220 and MHC class II, suggesting that they were not dislodged bone-marrow long-lived plasma cells, but newly differentiated migratory plasmablasts migrating to the bone marrow; thus reflective of an ongoing or developing immune response. Our data indicates that PBMC can be a useful source for malaria-specific memory B cells and plasma cells, but extrapolation of the results to human malaria infections suggests that timing of sampling, particularly for plasma cells, may be critical. Studies should therefore include multiple sampling points, and at times of infection/immunisation when the B-cell phenotypes of interest are likely to be found in peripheral blood

    Immunological aspects in chronic lymphocytic leukemia (CLL) development

    Get PDF
    Chronic lymphocytic leukemia (CLL) is unique among B cell malignancies in that the malignant clones can be featured either somatically mutated or unmutated IGVH genes. CLL cells that express unmutated immunoglobulin variable domains likely underwent final development prior to their entry into the germinal center, whereas those that express mutated variable domains likely transited through the germinal center and then underwent final development. Regardless, the cellular origin of CLL remains unknown. The aim of this review is to summarize immunological aspects involved in this process and to provide insights about the complex biology and pathogenesis of this disease. We propose a mechanistic hypothesis to explain the origin of B-CLL clones into our current picture of normal B cell development. In particular, we suggest that unmutated CLL arises from normal B cells with self-reactivity for apoptotic bodies that have undergone receptor editing, CD5 expression, and anergic processes in the bone marrow. Similarly, mutated CLL would arise from cells that, while acquiring self-reactivity for autoantigens—including apoptotic bodies—in germinal centers, are also still subject to tolerization mechanisms, including receptor editing and anergy. We believe that CLL is a proliferation of B lymphocytes selected during clonal expansion through multiple encounters with (auto)antigens, despite the fact that they differ in their state of activation and maturation. Autoantigens and microbial pathogens activate BCR signaling and promote tolerogenic mechanisms such as receptor editing/revision, anergy, CD5+ expression, and somatic hypermutation in CLL B cells. The result of these tolerogenic mechanisms is the survival of CLL B cell clones with similar surface markers and homogeneous gene expression signatures. We suggest that both immunophenotypic surface markers and homogenous gene expression might represent the evidence of several attempts to re-educate self-reactive B cells

    Tolerance-induced receptor selection: Scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection

    No full text
    Receptor editing is a mode of immunological tolerance of B lymphocytes that involves antigen-induced B-cell receptor signaling and consequent secondary immunoglobulin light chain gene recombination. This ongoing rearrangement often changes B-cell specificity for antigen, rendering the cell non-autoreactive and sparing it from deletion. We currently believe that tolerance-induced editing is limited to early stages in B-cell development and that it is a major mechanism of tolerance, with a low-affinity threshold and the potential to take place in virtually every developing B cell. The present review highlights the contributions from our laboratory over several years to elucidate these features

    Persistent Quaternary climate refugia are hospices for biodiversity in the Anthropocene

    No full text
    Published: 03 February 2020Climate stability leads to high levels of speciation and reduced extinction rates, shaping species richness patterns1,2,3. Hotspots of species diversity often overlap with regions that experienced stable temperatures and, perhaps, variable rates of precipitation during the late Quaternary4,5. These hotspots potentially harbour many species with low vagility and small geographical ranges6, making them more vulnerable to future ecoclimatic change4,7,8. By comparing global and regional patterns of climate stability during short periods of unusually large and widespread climate changes since the Last Glacial Maximum with twenty-first-century patterns, we show that human-driven climate change will disproportionally affect biodiversity in late Quaternary climate refugia, ultimately affecting the species, communities and ecosystems that are most vulnerable to climate change. Moreover, future changes in absolute temperature will probably erode the mechanisms that are theorized to sustain biodiversity hotspots across time. These impending shifts from stable to unstable temperatures—projected for the majority of the world’s biodiversity regions—threaten to reduce the size and extent of important climatic safe havens for diversity. Where climate refugia are forecast to persist until the end of this century, temperatures in these refuges are likely to exceed the acclimation capacity of many species, making them short-term hospices for biodiversity at best.Stuart C. Brown, Tom M. L. Wigley, Bette L. Otto-Bliesner, Carsten Rahbek and Damien A. Fordha
    corecore